http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : 김상요(Sangyo Kim) (검색결과 1 건)
- 무료
- 기관 내 무료
- 유료
-
규제과학의 개념과 발전전략 : 식품, 의약품, 의료기기를 중심으로
강대원(Daewon Kang),배은미(Eun-mi Bae),김상요(Sangyo Kim),김상현(Sanghyun Kim),최상은(Sang-Eun Choi) 대한약학회 2021 약학회지 Vol.65 No.5
Science areas related to evaluating the safety, efficacy, performance, and quality of a product can be referred to as regulatory science (RS). The Korean government recently announced plans to foster its regulatory capacity for drugs, medical devices, and foods. This study aims to clarify the characteristics of RS and their implications for how to develop RS in South Korea. We reviewed the literature and the websites of foreign regulatory bodies to determine the characteristics and development strategies of RS for drugs, medical devices, and foods. To understand the current status of RS in Korea, we reviewed the usage of the term “regulatory science” in academic literature and non-academic context. RS is a multidisciplinary science of a predictive nature that deals with uncertainty. In Korea, only one recent study discusses the characteristics of regulatory science in a specific context; the term RS has been used to mean “regulatory affairs” in Korean non-academic contexts. Seven types of structures were identified as fostering RS: a regulatory body supporting designated institutions, a partnership for research, networks of regulatory bodies, an RS center established by a government agency, a government agency dedicated for RS, an RS center established in a university, and individual university programs. Healthcare issues and available technology are important factors in deciding focus research areas. This study reviewed various aspects of RS and its current status in Korea to facilitate decisions on Korean RS development strategy.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
